COMMUNIQUÉS West-GlobeNewswire

Phase 1b/2 Study of Margetuximab in Combination with Pembrolizumab Presented at 2018 ASCO Gastrointestinal Cancers Symposium
18/01/2018
Chemotherapy-free, immunotherapeutic combination evaluated 32% Overall response rate in second-line gastric cancer patients Well tolerated in dose escalation and expansion cohorts Rockville, MD, Jan. 18, 2018 (GLOBE [...]
Adherium Corporate Headquarters Opens in Silicon Valley
18/01/2018
SAN MATEO, Calif., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, today announced the opening of its corporate headquarters in San [...]
Sight-Restorative Eye Donations and Transplants in Colorado and Wyoming Break Records
18/01/2018
DENVER, Jan. 18, 2018 (GLOBE NEWSWIRE) -- The number of eye donations in Colorado and Wyoming, and the number of sight-restorative corneal transplants performed as a result, were at an all-time high in 2017. According [...]
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2017 Financial Results Conference Call
18/01/2018
WALTHAM, Mass., Jan. 18, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO ) announced today that it plans to issue its fourth quarter and full year 2017 financial results before the opening of the market on [...]
Paratek Announces Pricing of Public Offering of Common Stock
18/01/2018
BOSTON, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in [...]
Imaging3 Announces Formation of a Scientific Advisory Board
18/01/2018
BURBANK, Calif., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Imaging3, Inc. (OTCQB:IGNG), a development stage company targeting disruptive technologies in the medical imaging industry, announced today the formation of a [...]
FIT Biotech Oy: FIT Biotech's CEO to change - Erkki Pekkarinen appointed as a new CEO
18/01/2018
FIT Biotech Oy Company release January 18, 2018 at 4.05 pm EET FIT Biotech's CEO to change - Erkki Pekkarinen appointed as a new CEO The Board of Directors of FIT Biotech Oy (the "Company") has appointed Vice Chairman [...]
Rexahn Pharmaceuticals to Present at the American Society of Clinical Oncology Gastrointestinal Cancers (ASCO GI) 2018 Annual Meeting
18/01/2018
ROCKVILLE, Md., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, [...]
Lexington Completes IRB Submission in Preparation for Clinical Study
18/01/2018
VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is pleased to announce it [...]
Clinical Genomics appoints Tadd Lazarus, M.D., as Chief Medical Officer
18/01/2018
BRIDGEWATER, N.J., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions and liquid biopsy tests, today announced the appointment of Tadd Lazarus, M.D., as Chief Medical [...]
Vilacto Bio Inc. Begins Development of the Vilacto Bio Skincare Knowledge Center
18/01/2018
COPENHAGEN, Denmark, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTCQB:VIBI), today announced that it has commenced development of the Vilacto Bio Skincare Knowledge Center, an online resource that will gather [...]
Xtant Medical Enters into Restructuring and Exchange Agreement with All Holders of Outstanding Convertible Notes
18/01/2018
Conversion of $1.627M (plus interest) of convertible notes into common stock Exchange of $70.238M (plus interest) of convertible notes into common stock Upon stockholder approval, amendment of Certificate of [...]
Canada House Wellness Group Update on Abba Medix Grow Progress
18/01/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Abba Medix Corp “Abba”, a subsidiary of Canada House Wellness Group Inc. (CSE:CHV) (“ [...]
Organovo Announces Release Date for Fiscal Third-Quarter 2018 Financial Results
18/01/2018
SAN DIEGO, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) will host a conference call on Thursday, February 8, 2018 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal [...]
Celsion Corporation Provides Corporate Update and 2018 Outlook
18/01/2018
Company Advances ThermoDox® for Treatment of Primary Liver Cancer Following Independent Data Monitoring Committee’s Unanimous Recommendation to Continue Phase III OPTIMA Study OPTIMA Study Enrollment Reached 74% [...]
Radient Technologies Inc. Announces Key Management Appointment to RTI Global Health and Wellness Solutions
18/01/2018
EDMONTON, Alberta, Jan. 18, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. ("Radient" or the “Corporation”) (TSX-V: RTI ) is pleased to announce the appointment of Dr. Marilena Radoiu to a key management role in its [...]
Argos Announces One-for-Twenty Reverse Stock Split
18/01/2018
DURHAM, N.C., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ: ARGS ), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis [...]
Caladrius Biosciences Announces Completion of Enrollment of Phase 2 T-Rex Clinical Trial of CLBS03 for Type 1 Diabetes
18/01/2018
BASKING RIDGE, N.J. , Jan. 18, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
AzurRx BioPharma Announces Receipt of Required Approvals to Add French Clinical Site for its Phase IIa Study of MS1819-SD for Exocrine Pancreatic Insufficiency
18/01/2018
BROOKLYN, N.Y., Jan. 18, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]

Pages